Jiangong Niu

3.5k total citations
79 papers, 2.6k citations indexed

About

Jiangong Niu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jiangong Niu has authored 79 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 25 papers in Molecular Biology and 19 papers in Cancer Research. Recurrent topics in Jiangong Niu's work include Genomics and Phylogenetic Studies (11 papers), Identification and Quantification in Food (10 papers) and Genetic diversity and population structure (9 papers). Jiangong Niu is often cited by papers focused on Genomics and Phylogenetic Studies (11 papers), Identification and Quantification in Food (10 papers) and Genetic diversity and population structure (9 papers). Jiangong Niu collaborates with scholars based in United States, China and Canada. Jiangong Niu's co-authors include Paul J. Chiao, Sharon H. Giordano, Bailu Peng, Zhongkui Li, Guido M. Sclabas, Douglas B. Evans, James L. Abbruzzese, Christian Schmidt, Shuichi Fujioka and Mariana Chávez‐MacGregor and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jiangong Niu

75 papers receiving 2.6k citations

Peers

Countries citing papers authored by Jiangong Niu

Since Specialization

Citations

This map shows the geographic impact of Jiangong Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangong Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangong Niu more than expected).

Fields of papers citing papers by Jiangong Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangong Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangong Niu. The network helps show where Jiangong Niu may publish in the future.

Co-authorship network of co-authors of Jiangong Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangong Niu. A scholar is included among the top collaborators of Jiangong Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangong Niu. Jiangong Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality 2025 ·Journal of Clinical Oncology ·Maureen Canavan, (unknown), (unknown), John K. Lin, David Hui, Hui Zhao, (unknown), Ravin Ratan, Nathan I. Cherny, Trinh Pham, Sharon H. Giordano, Jiangong Niu, Kerin B. Adelson	0
2	Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework 2024 ·JNCI Journal of the National Cancer Institute ·(unknown), Jiangong Niu, Martin C. Tammemägi, Ehsan Irajizad, Yu Shen, Karen H. Lu, Larissa A. Meyer, Iakovos Toumazis	4
3	Acceptability of Personalized Lung Cancer Screening Program Among Primary Care Providers 2024 ·Cancer Prevention Research ·(unknown), Jiangong Niu, Gabrielle F. Duhon, Lewis E. Foxhall, Sanjay Shete, Robert J. Volk, Iakovos Toumazis	1
4	Real-world neoadjuvant and adjuvant Trastuzumab-containing regimen patterns and their association with survival among patients with operable HER2-positive breast cancer from 2007 to 2021 2024 ·Breast Cancer Research and Treatment ·Hui Zhao, Chan Shen, (unknown), Xiudong Lei, Jiangong Niu, Sharon H. Giordano, (unknown)	0
5	Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening 2024 ·Cancer Medicine ·(unknown), Jiangong Niu, (unknown), Fengyi Jin, Kelly W. Merriman, Xiuning Le, Hormuzd A. Katki, John V. Heymach, Mara B. Antonoff, Edwin J. Ostrin, Jia Wu, Jianjun Zhang, Iakovos Toumazis	6
6	Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis. 2024 ·JCO Oncology Practice ·Kerin B. Adelson, Maureen Canavan, Jiangong Niu, Hui Zhao, Nico Nortjé, (unknown), Sharon H. Giordano, (unknown)	1
7	Estimates of the Effective Population Size and Genetic Structure of the Critically Endangered Ship Sturgeon (Acipenser nudiventris) in the Chinese Section of the Ili River 2023 ·Fishes ·Guo Hu, Chen Feng, Ying Zhang, (unknown), Zhiyuan Luo, Jiangong Niu, (unknown), (unknown), Tao Zhang, Yongjun Shu, Feng Ji	1
8	Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection 2023 ·The Annals of Thoracic Surgery ·Nicolas Zhou, Jiangong Niu, David Nelson, Hope Feldman, Mara B. Antonoff, Wayne L. Hofstetter, Reza J. Mehran, David C. Rice, Boris Sepesi, Stephen G. Swisher, Garret Walsh, Sharon H. Giordano, Ravi Rajaram	3
9	Shared Decision-Making for Lung Cancer Screening 2021 ·CHEST Journal ·Shawn Nishi, Lisa M. Lowenstein, Tito R. Mendoza, María A. López-Olivo, (unknown), Karen Sepucha, Jiangong Niu, Robert J. Volk	39
10	Quality Gaps and Comparative Effectiveness in Lung Cancer Staging and Diagnosis 2019 ·CHEST Journal ·David E. Ost, Jiangong Niu, Hui Zhao, Horiana B. Grosu, Sharon H. Giordano	19
11	Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients 2018 ·JACC. Cardiovascular imaging ·Mariana L. Henry, Jiangong Niu, Ning Zhang, Sharon H. Giordano, Mariana Chávez‐MacGregor	89
12	Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis 2017 ·Journal of Clinical Oncology ·David B. Nelson, David C. Rice, Jiangong Niu, Scott M. Atay, Ara A. Vaporciyan, Mara B. Antonoff, Wayne L. Hofstetter, Garrett L. Walsh, Stephen G. Swisher, Jack A. Roth, Anne S. Tsao, Daniel R. Gomez, Sharon H. Giordano, Reza J. Mehran, Boris Sepesi	58
13	Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions 2017 ·CHEST Journal ·David E. Ost, Jiangong Niu, Hui Zhao, Horiana B. Grosu, Sharon H. Giordano	51
14	Quality Gaps and Comparative Effectiveness in Lung Cancer Staging and Diagnosis 2013 ·CHEST Journal ·David E. Ost, Jiangong Niu, Linda S. Elting, Thomas A. Buchholz, Sharon H. Giordano	41
15	Determinants of Practice Patterns and Quality Gaps in Lung Cancer Staging and Diagnosis 2013 ·CHEST Journal ·David E. Ost, Jiangong Niu, Linda S. Elting, Thomas A. Buchholz, Sharon H. Giordano	26
16	Association between a functional polymorphism (‐1195T>C) in the IGFBP5 promoter and head and neck cancer risk 2010 ·Head & Neck ·Jiangong Niu, (unknown), Sheng Wei, Zhensheng Liu, Lie Wang, Shine Chang, Robert M. Chamberlain, Adel K. El‐Naggar, Erich M. Sturgis, Qingyi Wei	8
17	In vitro Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K- ras Oncogenic Activation in Pancreatic Carcinogenesis 2005 ·Cancer Research ·(unknown), Jiangong Niu, Ming Li, Paul J. Chiao, Ming‐Sound Tsao	94
18	Function of Polo-like Kinase 3 in NF-κB-mediated Proapoptotic Response 2005 ·Journal of Biological Chemistry ·Zhongkui Li, Jiangong Niu, Tadashi Uwagawa, Bailu Peng, Paul J. Chiao	47
19	NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity 2004 ·Molecular and Cellular Biology ·Shuichi Fujioka, Jiangong Niu, Christian Schmidt, Guido M. Sclabas, Bailu Peng, Tadashi Uwagawa, Zhongkui Li, Douglas B. Evans, James L. Abbruzzese, Paul J. Chiao	370
20	Role of Rel/NF‐κB transcription factors in apoptosis of human hepatocellular carcinoma cells 2002 ·Cancer ·Paul J. Chiao, (unknown), Jiangong Niu, Guido M. Sclabas, Qianggang Dong, Steven A. Curley	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact